These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38001904)

  • 41. Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation.
    Villani A; Scalvenzi M; Micali G; Lacarrubba F; Genco L; Ruggiero A; Fornaro L; Guerrasio G; Potestio L
    Expert Opin Drug Saf; 2023; 22(7):525-531. PubMed ID: 37326221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumor regression.
    Maier T; Kulichova D; Ruzicka T; Berking C
    J Am Acad Dermatol; 2014 Oct; 71(4):725-30. PubMed ID: 24928708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data.
    Nazzaro G; Benzecry V; Mattioli MA; Denaro N; Beltramini GA; Marzano AV; Passoni E
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas.
    Iljin A; Stasikowska-Kanicka O; Zieliñski T; Bąkiewicz A; Sporny S; Woźniak-Roszkowska E; Antoszewski B
    Postepy Dermatol Alergol; 2022 Oct; 39(5):980-985. PubMed ID: 36457690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
    Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
    Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma.
    Migden M; Farberg AS; Dummer R; Squittieri N; Hanke CW
    J Drugs Dermatol; 2021 Feb; 20(2):156-165. PubMed ID: 33538567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Approaches in Non-Melanoma Skin Cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).
    Chmiel P; Kłosińska M; Forma A; Pelc Z; Gęca K; Skórzewska M
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cutaneous basosquamous cell carcinoma].
    Lehnerdt G; Manz D; Jahnke K; Schmitz KJ
    HNO; 2008 Mar; 56(3):306-11. PubMed ID: 17464493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation.
    Cowey L; Chen CI; Aguilar KM; Davies K; LaFontaine PR; Fury MG; Bowler T; Golozar A; Jalbert JJ
    Dermatol Ther (Heidelb); 2022 May; 12(5):1211-1224. PubMed ID: 35507216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined cemiplimab and radiotherapy for advanced basal cell carcinoma: A case report.
    Sarfaraz S; Hayes RC; Hunt AM
    SAGE Open Med Case Rep; 2023; 11():2050313X231164248. PubMed ID: 37025249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma.
    Dummer R; Liu L; Squittieri N; Gutzmer R; Lear J
    Oncotarget; 2020 Sep; 11(37):3473-3483. PubMed ID: 32973971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
    Ashraf S; Alsharedi M
    Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience.
    Rouvinov K; Mazor G; Kozlener E; Meirovitz A; Shrem NS; Abu Saleh O; Shalata S; Yakobson A; Shalata W
    J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerance of sonidegib after intolerance of vismodegib-Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome).
    Venturi F; Trane L; Silvestri F; Zuccaro B; Magnaterra E; De Giorgi V
    Skin Health Dis; 2023 Oct; 3(5):e260. PubMed ID: 37799353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Basosquamous carcinoma: histopathological features.
    Lima NL; Verli FD; de Miranda JL; Marinho SA
    Indian J Dermatol; 2012 Sep; 57(5):382-3. PubMed ID: 23112359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area.
    Villani A; Fabbrocini G; Micali G; Fornaro L; Potestio L; Scalvenzi M
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2121-2126. PubMed ID: 37477769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside.
    Goodman DT
    JPRAS Open; 2022 Sep; 33():155-160. PubMed ID: 36046255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
    Fania L; Didona D; Morese R; Campana I; Coco V; Di Pietro FR; Ricci F; Pallotta S; Candi E; Abeni D; Dellambra E
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33113965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastasis of a basosquamous carcinoma arising in a nevus sebaceus.
    Ye Q; Shen X; Wang J; Li FZ; Fang S
    J Cutan Pathol; 2023 Apr; 50(4):306-309. PubMed ID: 36131688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants.
    Mitsuhashi T; Itoh T; Shimizu Y; Ban S; Ogawa F; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Mar; 33(3):246-52. PubMed ID: 16466514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.